ENTRY       mmu03320                    Pathway
NAME        PPAR signaling pathway - Mus musculus (mouse)
DESCRIPTION Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.
CLASS       Organismal Systems; Endocrine system
PATHWAY_MAP mmu03320  PPAR signaling pathway
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        12491  Cd36; CD36 molecule [KO:K06259]
            26457  Slc27a1; solute carrier family 27 (fatty acid transporter), member 1 [KO:K08745] [EC:6.2.1.-]
            26569  Slc27a4; solute carrier family 27 (fatty acid transporter), member 4 [KO:K08745] [EC:6.2.1.-]
            26458  Slc27a2; solute carrier family 27 (fatty acid transporter), member 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]
            26459  Slc27a5; solute carrier family 27 (fatty acid transporter), member 5 [KO:K08748] [EC:6.2.1.7]
            225579  Slc27a6; solute carrier family 27 (fatty acid transporter), member 6 [KO:K08749]
            14080  Fabp1; fatty acid binding protein 1, liver [KO:K08750]
            14079  Fabp2; fatty acid binding protein 2, intestinal [KO:K08751]
            14077  Fabp3; fatty acid binding protein 3, muscle and heart [KO:K08752]
            11770  Fabp4; fatty acid binding protein 4, adipocyte [KO:K08753]
            16592  Fabp5; fatty acid binding protein 5, epidermal [KO:K08754]
            16204  Fabp6; fatty acid binding protein 6 [KO:K08755]
            12140  Fabp7; fatty acid binding protein 7, brain [KO:K08756]
            19013  Ppara; peroxisome proliferator activated receptor alpha [KO:K07294]
            20181  Rxra; retinoid X receptor alpha [KO:K08524]
            20182  Rxrb; retinoid X receptor beta [KO:K08525]
            20183  Rxrg; retinoid X receptor gamma [KO:K08526]
            19015  Ppard; peroxisome proliferator activator receptor delta [KO:K04504]
            19016  Pparg; peroxisome proliferator activated receptor gamma [KO:K08530]
            208715  Hmgcs1; 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 [KO:K01641] [EC:2.3.3.10]
            15360  Hmgcs2; 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 [KO:K01641] [EC:2.3.3.10]
            11806  Apoa1; apolipoprotein A-I [KO:K08757]
            11807  Apoa2; apolipoprotein A-II [KO:K08758]
            11814  Apoc3; apolipoprotein C-III [KO:K08759]
            66113  Apoa5; apolipoprotein A-V [KO:K09025]
            18830  Pltp; phospholipid transfer protein [KO:K08761]
            17436  Me1; malic enzyme 1, NADP(+)-dependent, cytosolic [KO:K00029] [EC:1.1.1.40]
            109264  Me3; malic enzyme 3, NADP(+)-dependent, mitochondrial [KO:K00029] [EC:1.1.1.40]
            56473  Fads2; fatty acid desaturase 2 [KO:K10226] [EC:1.14.19.3]
            20249  Scd1; stearoyl-Coenzyme A desaturase 1 [KO:K00507] [EC:1.14.19.1]
            20250  Scd2; stearoyl-Coenzyme A desaturase 2 [KO:K00507] [EC:1.14.19.1]
            30049  Scd3; stearoyl-coenzyme A desaturase 3 [KO:K00507] [EC:1.14.19.1]
            329065  Scd4; stearoyl-coenzyme A desaturase 4 [KO:K00507] [EC:1.14.19.1]
            13122  Cyp7a1; cytochrome P450, family 7, subfamily a, polypeptide 1 [KO:K00489] [EC:1.14.14.23]
            13124  Cyp8b1; cytochrome P450, family 8, subfamily b, polypeptide 1 [KO:K07431] [EC:1.14.18.8 1.14.14.139]
            22259  Nr1h3; nuclear receptor subfamily 1, group H, member 3 [KO:K08536]
            104086  Cyp27a1; cytochrome P450, family 27, subfamily a, polypeptide 1 [KO:K00488] [EC:1.14.15.15]
            13167  Dbi; diazepam binding inhibitor [KO:K08762]
            13168  Dbil5; diazepam binding inhibitor-like 5 [KO:K08762]
            16956  Lpl; lipoprotein lipase [KO:K01059] [EC:3.1.1.34]
            14081  Acsl1; acyl-CoA synthetase long-chain family member 1 [KO:K01897] [EC:6.2.1.3]
            50790  Acsl4; acyl-CoA synthetase long-chain family member 4 [KO:K01897] [EC:6.2.1.3]
            216739  Acsl6; acyl-CoA synthetase long-chain family member 6 [KO:K01897] [EC:6.2.1.3]
            74205  Acsl3; acyl-CoA synthetase long-chain family member 3 [KO:K01897] [EC:6.2.1.3]
            433256  Acsl5; acyl-CoA synthetase long-chain family member 5 [KO:K01897] [EC:6.2.1.3]
            328845  Acsbg2; acyl-CoA synthetase bubblegum family member 2 [KO:K15013] [EC:6.2.1.3]
            94180  Acsbg1; acyl-CoA synthetase bubblegum family member 1 [KO:K15013] [EC:6.2.1.3]
            78625  Acsbg3; acyl-CoA synthetase bubblegum family member 3 [KO:K15013] [EC:6.2.1.3]
            108078  Olr1; oxidized low density lipoprotein (lectin-like) receptor 1 [KO:K08763]
            74147  Ehhadh; enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase [KO:K07514] [EC:4.2.1.17 1.1.1.35 5.3.3.8]
            13118  Cyp4a12b; cytochrome P450, family 4, subfamily a, polypeptide 12B [KO:K07425] [EC:1.14.14.80]
            13117  Cyp4a10; cytochrome P450, family 4, subfamily a, polypeptide 10 [KO:K07425] [EC:1.14.14.80]
            13119  Cyp4a14; cytochrome P450, family 4, subfamily a, polypeptide 14 [KO:K07425] [EC:1.14.14.80]
            435802  Cyp4a30b; cytochrome P450, family 4, subfamily a, polypeptide 30b [KO:K07425] [EC:1.14.14.80]
            230639  Cyp4a29; cytochrome P450, family 4, subfamily a, polypeptide 29 [KO:K07425] [EC:1.14.14.80]
            666168  Cyp4a31; cytochrome P450, family 4, subfamily a, polypeptide 31 [KO:K07425] [EC:1.14.14.80]
            100040843  Cyp4a32; cytochrome P450, family 4, subfamily a, polypeptide 32 [KO:K07425] [EC:1.14.14.80]
            277753  Cyp4a12a; cytochrome P450, family 4, subfamily a, polypeptide 12a [KO:K07425] [EC:1.14.14.80]
            113868  Acaa1a; acetyl-Coenzyme A acyltransferase 1A [KO:K07513] [EC:2.3.1.16]
            235674  Acaa1b; acetyl-Coenzyme A acyltransferase 1B [KO:K07513] [EC:2.3.1.16]
            20280  Scp2; sterol carrier protein 2, liver [KO:K08764] [EC:2.3.1.176]
            80911  Acox3; acyl-Coenzyme A oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]
            11430  Acox1; acyl-Coenzyme A oxidase 1, palmitoyl [KO:K00232] [EC:1.3.3.6]
            93732  Acox2; acyl-Coenzyme A oxidase 2, branched chain [KO:K10214] [EC:1.17.99.3]
            12894  Cpt1a; carnitine palmitoyltransferase 1a, liver [KO:K08765] [EC:2.3.1.21]
            12895  Cpt1b; carnitine palmitoyltransferase 1b, muscle [KO:K19523] [EC:2.3.1.21]
            78070  Cpt1c; carnitine palmitoyltransferase 1c [KO:K19524] [EC:2.3.1.21]
            12896  Cpt2; carnitine palmitoyltransferase 2 [KO:K08766] [EC:2.3.1.21]
            11363  Acadl; acyl-Coenzyme A dehydrogenase, long-chain [KO:K00255] [EC:1.3.8.8]
            11364  Acadm; acyl-Coenzyme A dehydrogenase, medium chain [KO:K00249] [EC:1.3.8.7]
            57875  Angptl4; angiopoietin-like 4 [KO:K08767]
            20411  Sorbs1; sorbin and SH3 domain containing 1 [KO:K06086]
            103968  Plin1; perilipin 1 [KO:K08768]
            11520  Plin2; perilipin 2 [KO:K17284]
            57435  Plin4; perilipin 4 [KO:K20254]
            66968  Plin5; perilipin 5 [KO:K20255]
            11450  Adipoq; adiponectin, C1Q and collagen domain containing [KO:K07296]
            83995  Mmp1a; matrix metallopeptidase 1a (interstitial collagenase) [KO:K01388] [EC:3.4.24.7]
            83996  Mmp1b; matrix metallopeptidase 1b (interstitial collagenase) [KO:K01388] [EC:3.4.24.7]
            22227  Ucp1; uncoupling protein 1 (mitochondrial, proton carrier) [KO:K08769]
            16202  Ilk; integrin linked kinase [KO:K06272] [EC:2.7.11.1]
            18607  Pdpk1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            22190  Ubc; ubiquitin C [KO:K08770]
            18534  Pck1; phosphoenolpyruvate carboxykinase 1, cytosolic [KO:K01596] [EC:4.1.1.32]
            74551  Pck2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) [KO:K01596] [EC:4.1.1.32]
            14933  Gk; glycerol kinase [KO:K00864] [EC:2.7.1.30]
            14626  Gk2; glycerol kinase 2 [KO:K00864] [EC:2.7.1.30]
            11832  Aqp7; aquaporin 7 [KO:K08771]
COMPOUND    C02165  Leukotriene B4
            C14762  13(S)-HODE
            C14767  9(S)-HODE
            C14776  8(S)-HETE
            C15493  9-cis-Retinoic acid
REFERENCE   PMID:15828220
  AUTHORS   Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.
  TITLE     [The structures and functions of peroxisome proliferator-activated receptors (PPARs)]
  JOURNAL   Nippon Rinsho 63:557-64 (2005)
REFERENCE   PMID:15828221
  AUTHORS   Fujii H.
  TITLE     [PPARs-mediated intracellular signal transduction]
  JOURNAL   Nippon Rinsho 63:565-71 (2005)
REFERENCE   PMID:15828222
  AUTHORS   Takada I, Kato S.
  TITLE     [PPARs target genes]
  JOURNAL   Nippon Rinsho 63:573-7 (2005)
REFERENCE   PMID:15828223
  AUTHORS   Inoue H.
  TITLE     [Endogenous ligands for PPARs]
  JOURNAL   Nippon Rinsho 63:578-83 (2005)
REFERENCE   PMID:16476485
  AUTHORS   Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.
  TITLE     From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
  JOURNAL   Prog Lipid Res 45:120-59 (2006)
            DOI:10.1016/j.plipres.2005.12.002
REFERENCE   PMID:16601267
  AUTHORS   Desvergne B, Michalik L, Wahli W.
  TITLE     Transcriptional regulation of metabolism.
  JOURNAL   Physiol Rev 86:465-514 (2006)
            DOI:10.1152/physrev.00025.2005
REFERENCE   PMID:14999402
  AUTHORS   Mandard S, Muller M, Kersten S.
  TITLE     Peroxisome proliferator-activated receptor alpha target genes.
  JOURNAL   Cell Mol Life Sci 61:393-416 (2004)
            DOI:10.1007/s00018-003-3216-3
REFERENCE   PMID:10529898
  AUTHORS   Desvergne B, Wahli W.
  TITLE     Peroxisome proliferator-activated receptors: nuclear control of metabolism.
  JOURNAL   Endocr Rev 20:649-88 (1999)
            DOI:10.1210/edrv.20.5.0380
REFERENCE   PMID:15673477
  AUTHORS   Savage DB.
  TITLE     PPARgamma as a metabolic regulator: insights from genomics and pharmacology.
  JOURNAL   Expert Rev Mol Med 2005:1-16 (2005)
            DOI:10.1017/S1462399405008793
REFERENCE   PMID:16511590
  AUTHORS   Semple RK, Chatterjee VK, O'Rahilly S.
  TITLE     PPAR gamma and human metabolic disease.
  JOURNAL   J Clin Invest 116:581-9 (2006)
            DOI:10.1172/JCI28003
REFERENCE   PMID:16360030
  AUTHORS   Lehrke M, Lazar MA.
  TITLE     The many faces of PPARgamma.
  JOURNAL   Cell 123:993-9 (2005)
            DOI:10.1016/j.cell.2005.11.026
REFERENCE   PMID:11921433
  AUTHORS   Hauner H.
  TITLE     The mode of action of thiazolidinediones.
  JOURNAL   Diabetes Metab Res Rev 18 Suppl 2:S10-5 (2002)
            DOI:10.1002/dmrr.249
REL_PATHWAY mmu00071  Fatty acid degradation
            mmu00072  Synthesis and degradation of ketone bodies
            mmu00120  Primary bile acid biosynthesis
            mmu00564  Glycerophospholipid metabolism
            mmu04920  Adipocytokine signaling pathway
KO_PATHWAY  ko03320
///
